Immunotherapy Approved for Small Cell Lung Cancer

Immunotherapy Approved for Small Cell Lung Cancer2018-08-23T20:10:31+00:00

Immunotherapy Treatments Approved for Small Cell Lung Cancer

The following immunotherapy is approved as a 3rd treatment (after two other treatments are no longer working):

APPROVED THERAPY:

  • Opdivo (nivolumab, a PD-1 inhibitor)

Click here for answers to frequently asked questions about immunotherapy for lung cancer.

No announcement available or all announcement expired.